UnknownPhase 3NCT04464850

Intravenous Versus Oral Iron Therapy in Hemodialysis Patients

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chiang Mai University
Principal Investigator
Kajohnsak Noppakun, MD
Instructor, Division of Nephrology, Department of Internal Medicine
Intervention
Intravenous iron(drug)
Enrollment
124 enrolled
Eligibility
18 years · All sexes
Timeline
20202022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04464850 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials